<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="25183">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02040714</url>
  </required_header>
  <id_info>
    <org_study_id>IPSG 001</org_study_id>
    <nct_id>NCT02040714</nct_id>
  </id_info>
  <brief_title>Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease</brief_title>
  <acronym>IPSG1</acronym>
  <official_title>Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Texas Scottish Rite Hospital for Children</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Texas Scottish Rite Hospital for Children</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Legg-Calvé-Perthes disease is a childhood hip disorder which is common enough to be a
      significant public health problem (affects 1 in 740 boys between ages 0—14), but uncommon
      enough to have a sufficient number of patients from a single institution to perform a
      definitive prospective study comparing the results of current treatments.  The present study
      will establish a database of prospectively identified patients with Legg-Calvé-Perthes (LCP)
      Disease and collect information regarding their presentation, treatment, and outcomes in the
      course of receiving currently available treatments.

      This study seeks to compare the outcomes of current treatments in the management of three
      age groups (ages 6—8, 8—11, &gt;11) of patients with Perthes disease at two- and five-year
      followup.  For each age group, two to three common treatment regimens currently used by
      practicing pediatric orthopaedic surgeons will be compared. The intervention a patient
      receives is determined through physician preference. Physicians pick an intervention for
      each age group and treat each patient with the same intervention.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Approximately 40 pediatric orthopaedic surgeons from pediatric centers in the US and other
      countries have agreed to participate in this database as members of the International
      Perthes Study Group (IPSG).  TSRH will be the lead center.  Those who agree to participate
      will seek IRB approval from their own institutions.  Data will be collected prospectively
      and entered into REDCap (Research Electronic Data Capture), a browser-based research
      database. PROMIS questionnaires will be completed via an online testing system, the NIH
      funded Assessment Center.

      For the 6—8 age patient group, the surgeons who treat their patients with one of the
      following three treatment regimens currently used in practice will be asked to participate
      in the study.

        1. Nonoperative management (i.e., without osteotomy);

        2. Operative containment treatment (femoral or pelvic osteotomy or Shelf acetabuloplasty)
           rendered in the early stage of the disease process (stage I); or,

        3. Operative containment treatment (femoral or pelvic osteotomy or Shelf acetabuloplasty)
           rendered in the later stage of the disease process (stage II).

      For the 8—11 patient age group, the same treatment regimens will be studied:

        1. Nonoperative management (i.e., without osteotomy);

        2. Operative containment treatment (femoral or pelvic osteotomy or Shelf acetabuloplasty)
           with 6 weeks post-operative non-weight bearing; and,

        3. Operative containment treatment (femoral or pelvic osteotomy or Shelf acetabuloplasty)
           with 6 months post-operative non-weight bearing.

      For the &gt;11 patient age group, it is known the patients generally have poor prognosis and
      that the above treatments do not work well.  Thus, we will collect prospective data from
      surgeons who are currently treating their patients with one of the following alternative
      treatment regimens 5,6:

        1. Core decompression or multiple epiphyseal drilling of the necrotic femoral head; or,

        2. Hip arthrodiastasis (application of hinged hip distractor) and core
           decompression/multiple epiphyseal drilling.

        3. Non-operative management of symptoms with non-weight bearing

      Physicians participating in the study determine their preferred treatment arms for each age
      group and then enroll patients into arms according to the physicians declared treatment
      preference for the age group. Patient families have the option to elect nonoperative
      management even if it is the non-preferred treatment option of the physician.

      Information regarding patient characteristics at presentation, physical exam findings,
      responses to Perthes patient and/or outcomes questionnaires, and results of radiographic and
      MR imaging studies will be collected.  Participants will be assigned a unique study number.
      A secure web application, REDCap, will be used to capture and store research information
      including de-identified radiographic and MR images, clinical information, and Perthes
      patient and/or outcomes questionnaire responses.

      All patients willing to complete the PROMIS questionnaires will do so regardless of group,
      treatment, or stage of the disease. The administration of the instrument is facilitated by
      the use of an online testing platform, the NIH-funded Assessment Center. Data will be
      transmitted and stored on a secure and dedicated server for the purpose of this study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">September 2023</completion_date>
  <primary_completion_date type="Anticipated">September 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Sphericity deviation score of the femoral head</measure>
    <time_frame>5 years post intervention</time_frame>
    <safety_issue>No</safety_issue>
    <description>The primary outcome for each age group will be a quantitative estimate of the sphericity of the femoral head as a measure of femoral head deformity. A more deformed head will be less spherical. Greater deformity leads to an increased risk of arthritis early in life.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Perfusion percentage</measure>
    <time_frame>Just after diagnosis of Perthes disease</time_frame>
    <safety_issue>No</safety_issue>
    <description>The perfusion percentage is a measure of the amount of blood flow in the femoral head relative to the volume of the whole head. This measure is calculated from the perfusion MRI images that are collected just prior to the application of the intervention.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Stulberg classification</measure>
    <time_frame>at 2 years and 5 years post intervention</time_frame>
    <safety_issue>No</safety_issue>
    <description>The Stulberg classification is a categorical system used to describe the shape of the femoral head that is traditionally used to evaluate outcomes and arthritis risk for patients with Perthes disease.</description>
  </other_outcome>
  <number_of_groups>9</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Legg Calve Perthes Disease</condition>
  <arm_group>
    <arm_group_label>Nonoperative management between ages 6-8</arm_group_label>
    <description>The choice of non-osteotomy management without containment or surgical containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Operative containment between age 6-8 in early stage</arm_group_label>
    <description>Operative containment treatment (femoral or pelvic osteotomy or Shelf acetabuloplasty)  rendered in the early stage of the disease process (stage I)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Operative containment between age 6-8 in the late stages</arm_group_label>
    <description>This arm examines operative containment treatment (femoral or pelvic osteotomy or Shelf acetabuloplasty) rendered in the later stage of the disease process (stage II)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nonoperative management between age 8-11</arm_group_label>
    <description>Patients who do not undergo some form of containment surgery because of medical, social, or other reasons will receive no surgical treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Operative containment with short-term non-weightbearing</arm_group_label>
    <description>As per the current standard practice for patients between age 8-11 in developed countries, all patients will undergo some form of containment surgery (pelvic or femoral osteotomy) in order to better &quot;contain&quot; the femoral head underneath the acetabulum. Post-operative treatment will include 6 weeks of non-weight bearing on the operated leg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Operative containment with prolonged non-weightbearing</arm_group_label>
    <description>As per the current standard practice for patients between age 8-11, all patients will undergo some form of containment surgery (pelvic or femoral osteotomy) in order to better &quot;contain&quot; the femoral head underneath the acetabulum. Post-operative treatment will include 6 months of non-weight bearing on the operated leg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Multiple epiphyseal drilling for patients over age 11</arm_group_label>
    <description>Patients will receive Multiple drilling and be non weight bearing for 6 months according to the treating physician's preference</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Multiple epiphyseal drilling and arthrodiastasis</arm_group_label>
    <description>Patients will undergo multiple epiphyseal drilling with application of fixator for 3-4 months followed by 8-12 weeks of non-weight bearing after fixator removal.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-surgical management in over 11 age group</arm_group_label>
    <description>Patients will be non-weight bearing and receive physical therapy according to the physician preferences.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>osteotomy</intervention_name>
    <description>Surgical procedures that improve femoral head containment</description>
    <arm_group_label>Operative containment between age 6-8 in early stage</arm_group_label>
    <arm_group_label>Operative containment between age 6-8 in the late stages</arm_group_label>
    <arm_group_label>Operative containment with short-term non-weightbearing</arm_group_label>
    <arm_group_label>Operative containment with prolonged non-weightbearing</arm_group_label>
    <other_name>Femoral osteotomy</other_name>
    <other_name>Shelf osteotomy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>multiple epiphyseal drilling</intervention_name>
    <description>Multiple epiphyseal drilling is a procedure that creates small holes in the femoral head growth plate to increase blood flow into the femoral head.</description>
    <arm_group_label>Multiple epiphyseal drilling for patients over age 11</arm_group_label>
    <arm_group_label>Multiple epiphyseal drilling and arthrodiastasis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants with a recent diagnosis of Perthes disease that are being followed by a
        participating orthopedic surgeon. Participants are invited to participate during a visit
        to their treating hospital.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with Legg-Calvé-Perthes disease

          -  Between age 6-16

          -  Patients with possible secondary femoral osteonecrosis if over the age of 11 due to
             trauma or corticosteroid therapy are also eligible.

        Exclusion Criteria:

          -  Patients with previous surgical treatment
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Harry KW Kim, MD, MS</last_name>
    <role>Study Chair</role>
    <affiliation>Texas Scottish Rite Hospital for Children</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jamie K Burgess, PhD</last_name>
    <phone>(214) 559-8569</phone>
    <email>jamie.burgess@tsrh.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Harry Kim, MD</last_name>
    <phone>(214) 559-7620</phone>
    <email>harry.kim@tsrh.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shawn Gilbert, MD</last_name>
      <phone>205-975-7499</phone>
      <email>srgilbert@uabmc.edu</email>
    </contact>
    <investigator>
      <last_name>Shawn Gilbert, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Phoenix Children's Hospital</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Judson Karlen, MD</last_name>
      <phone>602-546-1000</phone>
      <phone_ext>85927</phone_ext>
      <email>jkarlen@phoenixchildrens.com</email>
    </contact>
    <investigator>
      <last_name>Judson Karlen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Choi, MD</last_name>
      <email>pchoi@chla.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Paul Choi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Hospital</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eduardo Novais, MD</last_name>
      <phone>720-777-6600</phone>
      <email>Eduardo.Novais@childrenscolorado.org</email>
    </contact>
    <investigator>
      <last_name>Eduardo Novais, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Connecticut Children's Medical Center</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philip Mack, MD</last_name>
      <phone>660-545-8643</phone>
      <email>pwmack60@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Philip Mack, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nemours/Alfred I. duPont Hospital for Children</name>
      <address>
        <city>Wilmington</city>
        <state>Delaware</state>
        <zip>19803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mihir Thacker, MS, DNB, FCPS (Ortho)</last_name>
      <phone>302-651-4200</phone>
      <email>mthacker@nemours.org</email>
    </contact>
    <investigator>
      <last_name>Mihir Thacker, MS, DNB, FCPS (Ortho)</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's National Medical Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin Martin, MD</last_name>
      <phone>202-476-4063</phone>
      <email>bdmartin@childrensnational.org</email>
    </contact>
    <investigator>
      <last_name>Benjamin Martin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Orthopaedics of Atlanta</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tim Schrader, MD</last_name>
      <phone>678-686-6816</phone>
      <email>tschrad@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Tim Schrader, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lurie Children's Hospital of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph Janicki, MD</last_name>
      <email>jjanicki@luriechildrens.org</email>
    </contact>
    <investigator>
      <last_name>Joseph Janicki, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21218</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Boston</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115-5724</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Noelle Larson, MD</last_name>
      <phone>507-284-2995</phone>
      <email>Larson.Noelle@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Noelle Larson, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gillette Children's Specialty Healthcare</name>
      <address>
        <city>St. Paul</city>
        <state>Minnesota</state>
        <zip>55101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Laine, MD</last_name>
      <phone>651-578-5061</phone>
      <email>Jennifer.Laine@Gillettechildrens.com</email>
    </contact>
    <investigator>
      <last_name>Jennifer Laine, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stephen Sundberg, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Montefiore Greene Medical Arts Pavilion</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Fornari, MD</last_name>
      <phone>718-920-2060</phone>
      <email>efornari@montefiore.org</email>
    </contact>
    <investigator>
      <last_name>Eric Fornari, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York Presbyterian Hospital (Columbia Campus)</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joshua Hyman, MD</last_name>
      <phone>212-305-5475</phone>
      <email>jh736@columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Joshua Hyman, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NYU Hospital for Joint Diseases</name>
      <address>
        <city>New York City</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>OrthoCarolina</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Virginia Casey, MD</last_name>
      <phone>704-323-2543</phone>
      <email>Virginia.Casey@orthocarolina.com</email>
    </contact>
    <investigator>
      <last_name>Virginia Casey, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles Mehlman, DO, MPH</last_name>
      <phone>513-636-4087</phone>
      <email>Charles.Mehlman@cchmc.org</email>
    </contact>
    <contact_backup>
      <last_name>Junichi Tamai, MD</last_name>
      <phone>513-636-4785</phone>
      <email>junichi.tamai@cchmc.org</email>
    </contact_backup>
    <investigator>
      <last_name>Charles Mehlman, DO, MPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Junichi Tamai, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kevin Klingele, MD</last_name>
      <phone>614-722-3390</phone>
      <email>Kevin.Klingele@nationwidechildrens.org</email>
    </contact>
    <investigator>
      <last_name>Kevin Klingele, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wudbhav Sankar, MD</last_name>
      <phone>215-590-1527</phone>
      <email>sankarw@email.chop.edu</email>
    </contact>
    <investigator>
      <last_name>Wudbhav Sankar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Tennessee-Campbell Clinic</name>
      <address>
        <city>Germantown</city>
        <state>Tennessee</state>
        <zip>38138</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Derek M Kelly, MD</last_name>
      <phone>901-759-5552</phone>
      <email>dkelly@campbellclinic.com</email>
    </contact>
    <investigator>
      <last_name>Derek M Kelly, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Scottish Rite Hospital for Children</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jamie Burgess</last_name>
      <phone>214-559-8569</phone>
      <email>jamie.burgess@tsrh.org</email>
    </contact>
    <investigator>
      <last_name>Harry Kim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tony Herring, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Children's Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scott Rosenfeld, MD</last_name>
      <phone>832-822-3109</phone>
      <email>sbrosenf@texaschildrens.org</email>
    </contact>
    <investigator>
      <last_name>Scott Rosenfeld, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shriners Hospital for Children, Salt Lake City</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Seattle Children's Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Klane White, MD, MSC</last_name>
      <phone>206-987-5678</phone>
      <email>klane.white@seattlechildrens.org</email>
    </contact>
    <investigator>
      <last_name>Klane White, MD, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universidade de São Paulo</name>
      <address>
        <city>São Paulo</city>
        <zip>05508-070</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberto Guarniero, MSc, PhD, FSBOT</last_name>
      <email>robertoguarniero@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Roberto Guarniero, MSc, PhD, FSBOT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Calgary</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 4N1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>BC Children's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6H 3V4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>IWK Health Centre</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3K 6R8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Hospital for Sick Children</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrew Howard, MD, FRCSC</last_name>
      <phone>416-813-6430</phone>
      <email>andrew.howard@sickkids.ca</email>
    </contact>
    <investigator>
      <last_name>Andrew Howard, MD, FRCSC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children`s Hospital Hamburg-Altona</name>
      <address>
        <city>Hamburg</city>
        <zip>22763</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ralf Stuecker, MD</last_name>
      <phone>040 88908382</phone>
      <email>ralf.stuecker@kinderkrankenhaus.net</email>
    </contact>
    <investigator>
      <last_name>Ralf Stuecker, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kinderzentrum Mecklenburg</name>
      <address>
        <city>Schwerin</city>
        <zip>22609</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ludwig Meiss, MD</last_name>
      <email>l.meiss@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Barbara Behnke</last_name>
      <email>Barbara.Behnke@uksh.de</email>
    </contact_backup>
    <investigator>
      <last_name>Ludwig Meiss, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kasturba Medical College (KMC), Manipal</name>
      <address>
        <city>Manipal</city>
        <state>Karnataka</state>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hitesh Shah</last_name>
      <phone>0820- 2922754</phone>
      <email>hiteshshah12@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Benjamin Joseph, MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hitesh Shah</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seoul National University Childrens Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>WonJoon Yoo, MD</last_name>
      <email>yoowj@snu.ac.kr</email>
    </contact>
    <investigator>
      <last_name>WonJoon Yoo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shriners Hospital for Children</name>
      <address>
        <city>Mexico City</city>
        <state>Mexico, DF</state>
        <zip>04600</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pablo Castañeda, MD</last_name>
      <phone>5255 16647064</phone>
      <email>pablocastaneda@me.com</email>
    </contact>
    <investigator>
      <last_name>Pablo Castañeda, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ola Wiig, MD, PhD</last_name>
      <phone>+4795168380</phone>
      <email>ola.wiig@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ola Wiig, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University of Lodz, Poland</name>
      <address>
        <city>Lodz</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marek Synder, MD</last_name>
    </contact>
    <investigator>
      <last_name>Marek Synder, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bristol Royal Hospital for Children</name>
      <address>
        <city>Bristol</city>
        <state>Avon</state>
        <zip>BS2 8BJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sanjeev Madan</name>
      <address>
        <city>Sheffield</city>
        <state>South Yorkshire</state>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Southampton</name>
      <address>
        <city>Southampton</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
    <country>Brazil</country>
    <country>Canada</country>
    <country>Germany</country>
    <country>India</country>
    <country>Korea, Republic of</country>
    <country>Mexico</country>
    <country>Norway</country>
    <country>Poland</country>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://www.perthesdisease.org</url>
  </link>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 1, 2014</lastchanged_date>
  <firstreceived_date>January 2, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Texas Scottish Rite Hospital for Children</investigator_affiliation>
    <investigator_full_name>Harry Kim, MD</investigator_full_name>
    <investigator_title>Director of Research</investigator_title>
  </responsible_party>
  <keyword>femur head necrosis</keyword>
  <keyword>hip</keyword>
  <keyword>pediatric orthopedics</keyword>
  <keyword>MRI</keyword>
  <keyword>Osteonecrosis</keyword>
  <keyword>Bone diseases</keyword>
  <keyword>Legg Calve Perthes Syndrome</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Legg-Perthes Disease</mesh_term>
    <mesh_term>Scheuermann Disease</mesh_term>
    <mesh_term>Spinal Osteochondrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
